id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2013-D-1445-0074,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2020-10-05T04:00:00Z,2020,10,2020-10-05T04:00:00Z,,2024-11-06T23:40:06Z,,1,0,09000064848d3169
FDA-2013-D-1445-0073,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use Guidance for Industry and Food and Drug Administration Staff,Other,Guidance,2020-09-29T04:00:00Z,2020,9,2020-09-29T04:00:00Z,,2024-11-06T23:40:18Z,,1,0,090000648489b73e
FDA-2013-D-1445-0072,FDA,FDA-2013-D-1445,Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use; Guidance for Industry and  Food and Drug Administration Staff; Availability,Notice,Notice of Availability,2020-09-29T04:00:00Z,2020,9,2020-09-29T04:00:00Z,,2020-09-29T19:06:55Z,2020-21463,0,0,090000648489886d